Work

The combination of HE4 and CA-125 is superior to either marker alone for monitoring women with ovarian cancer

Year: 2020

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.05.088

Authors: A. Samborski, A.M. Blackman, M.C. Miller, S. MacLaughlan David, A.L. Jackson, E. Eklund, G. Messerlian, R.G. Moore

Institutions: University of Rochester Medicine, University of Rochester, University of Illinois Chicago, University of Cincinnati Medical Center, Brown University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096062546

FWCI:

Cites:

Cited by: 1

Related to: 10